Iron isomaltoside 1000 (MonoVer®)

 

 

Assessment Status Rapid Review Complete
HTA ID -
Drug Iron isomaltoside 1000
Brand MonoVer®
Indication For the treatment of iron deficiency anaemia in the following circumstances: When oral iron preparations are ineffective or cannot be used and where there is a clinical need to deliver iron rapidly.
Assessment Process
Rapid review commissioned 10/01/2011
Rapid review completed 02/02/2011
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended